Clinical Trials Browser

Completed × OTHER × HER2-positive Breast Cancer × Clear all

NCT07115095 2025-08-11

Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer

Phase NA Completed

HER2-positive Breast Cancer

NCT04756921 2021-02-16

18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response

HER2-positive Breast Cancer

NCT02135159 2017-08-14

BIRTH

Phase 1 Completed

HER2-positive Breast Cancer